ANGPT2 and breast carcinoma: In fact, although ANG2 overexpression increases the number of TEMs in breast cancer [28], monoclonal antibodies blocking ANG2 inhibits TEM interaction with blood vessel endothelial cells in a PyMT mouse model of breast cancer, limiting their supportive nature and pro-angiogenic function on endothelium [26].